Synonyms: example 7i [US8501735]
Compound class:
Synthetic organic
Comment: The chemical structure for frevecitinib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a Janus kinase inhibitor with anti-inflammatory potential. The structure matched example 7i in Palau Pharma's patent US8501735 [1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
3-[(3S)-3-(1-methyl-2-oxo-5-pyrazolo[1,5-a]pyridin-3-ylimidazo[4,5-b]pyridin-3-yl)piperidin-1-yl]-3-oxopropanenitrile |
International Nonproprietary Names ![]() |
|
INN number | INN |
13027 | frevecitinib |
Synonyms ![]() |
example 7i [US8501735] |
Database Links ![]() |
|
CAS Registry No. | 1299417-07-4 (source: WHO INN record) |
GtoPdb PubChem SID | 491299988 |
PubChem CID | 67123870 |
Search Google for chemical match using the InChIKey | ASOKEXGIQLZRHH-HNNXBMFYSA-N |
Search Google for chemicals with the same backbone | ASOKEXGIQLZRHH |
Search PubMed clinical trials | frevecitinib |
Search PubMed titles | frevecitinib |
Search PubMed titles/abstracts | frevecitinib |
UniChem Compound Search for chemical match using the InChIKey | ASOKEXGIQLZRHH-HNNXBMFYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | ASOKEXGIQLZRHH-HNNXBMFYSA-N |